bpc 157 hims jumps more than 7% after an FDA panel recommends adding BPC-157 to the 503A compounding list potentially opening a new peptide category. The opportunity fits Hims existing telehealth, compounding and customer The peptide craze
The peptide craze Hims & Hers Stock Pops on FDA Panel's Peptide Recommendation Barron's BPC 157 Precision Performance Physical Therapy Confirmed: The FDA just moved BPC 157 one step closer to compounded access. This could unleash an entirely new revenue stream. $HIMS
Pay in 4 interest-free payments of $6.25 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 1 - Aug 6

